Editas Medicine, Inc. short interest in 2024
In 2024, Editas Medicine, Inc.'s disclosed short interest ran from 15.28% of shares outstanding on 12 Jan 2024 to 22.06% on 31 Dec 2024, a change of +6.78 percentage points. The year's high was 26.78% on 31 May 2024 and its low 14.95% on 31 Jan 2024, averaging 20.62% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 12.83 days on 30 Aug 2024. Full history: Editas Medicine, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 15.28% (12 Jan 2024)
- End of year
- 22.06% (31 Dec 2024)
- Change
- +6.78 pp
- High
- 26.78% (31 May 2024)
- Low
- 14.95% (31 Jan 2024)
- Average
- 20.62%
- Highest days to cover
- 12.83 (30 Aug 2024)
- SEC filings marked
- 9
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 15.28% | 8.40 | |
| 31 Jan 2024 | 14.95% | 8.54 | |
| 15 Feb 2024 | 15.41% | 7.51 | |
| 29 Feb 2024 | 16.55% | 5.55 | 10-K filed, results (8-K) |
| 15 Mar 2024 | 17.05% | 6.11 | |
| 28 Mar 2024 | 20.03% | 9.23 | |
| 15 Apr 2024 | 22.97% | 11.16 | |
| 30 Apr 2024 | 25.11% | 12.52 | |
| 15 May 2024 | 25.25% | 9.76 | 10-Q filed, results (8-K) |
| 31 May 2024 | 26.78% | 11.88 | |
| 14 Jun 2024 | 26.39% | 10.25 | |
| 28 Jun 2024 | 20.36% | 4.95 | |
| 15 Jul 2024 | 19.20% | 9.90 | |
| 31 Jul 2024 | 19.62% | 10.63 | |
| 15 Aug 2024 | 20.49% | 9.59 | 10-Q filed, results (8-K) |
| 30 Aug 2024 | 21.83% | 12.83 | |
| 13 Sep 2024 | 22.99% | 12.18 | |
| 30 Sep 2024 | 20.30% | 6.79 | |
| 15 Oct 2024 | 22.23% | 9.38 | |
| 31 Oct 2024 | 20.88% | 8.84 | results (8-K) |
| 15 Nov 2024 | 19.27% | 7.08 | 10-Q filed, results (8-K) |
| 29 Nov 2024 | 19.46% | 6.04 | |
| 13 Dec 2024 | 20.51% | 5.12 | |
| 31 Dec 2024 | 22.06% | 6.03 |
See also: Editas Medicine, Inc.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.